Results 261 to 270 of about 721,295 (295)

Experimental Hypertension and the Arterial Lesions in the Rabbit

, 1933
Michael Kremer, Samson Wright, R. W. Scarff   +2 more
openalex   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

SCM-198 ameliorates pulmonary arterial hypertension by modulating gut microbiota in rats. [PDF]

J Thorac Dis
Xiong J, Ge Q, Fu B, Li J, Lin Z, Zhu YZ.   +5 more
europepmc   +1 more source

The importance of taste salt sensitivity in the development of kidney damage in patients with high-risked arterial hypertension [PDF]

G Khamidullaeva, K H H Ataniyazov, N Jabbarova, Shakhlo Fayzullaeva, Khurshid Fozilov   +4 more
openalex   +1 more source

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T. Muanda   +2 more
wiley   +1 more source

How the Latest Guidelines Are Changing the Diagnostic and Therapeutic Landscape of Arterial Hypertension. [PDF]

J Clin Med
Pastore MC, Carmona De Azevedo Bellagamba C, Liga R, Stefanini A, Durante M, D'Ascenzi F, Pedrinelli R, Cameli M.   +7 more
europepmc   +1 more source

Possible therapeutic repositioning of valproic acid: From epileptic seizures to acute kidney injury

British Journal of Clinical Pharmacology, EarlyView.
Valproic acid, an anticonvulsant, may be repositioned to prevent acute kidney injury due to ischemia followed by reperfusion. It preserves renal functions, electrolyte homeostasis and active sodium transport in kidney tubules, and blocks the onset of hypertension.
Danilo Alves‐Bezerra, Luiza B. Negreiros, Amaury Pereira‐Acácio, Isadora G. Almeida, João P. M. Veloso‐Santos, Jarlene A. Lopes, Glória Costa‐Sarmento, Humberto Muzi‐Filho, Adalberto Vieyra   +8 more
wiley   +1 more source

An easily overlooked cause of pulmonary arterial hypertension-thiamine deficiency. [PDF]

Front Nutr
Zhao Q, Li M, Chen L, Qiu F.
europepmc   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Arterial Hypertension: Highlights from the European Society of Cardiology 2025 Congress. [PDF]

Eur Cardiol
Lorenza Muiesan M, Lemoli M.
europepmc   +1 more source